Detalhe da pesquisa
1.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(4): 323-334, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990608
2.
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
J Urol
; 209(5): 882-889, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795962
3.
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
N Engl J Med
; 381(2): 121-131, 2019 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157964
4.
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
J Urol
; 207(1): 70-76, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445891
5.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
6.
Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer.
Acta Oncol
; 61(3): 294-301, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726566
7.
The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review.
Oncologist
; 26(8): e1381-e1394, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028134
8.
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
BJU Int
; 127(5): 528-537, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981193
9.
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
BJU Int
; 128(1): 79-87, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152179
10.
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
World J Urol
; 39(12): 4345-4354, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370078
11.
Hypothyroïdie causée par l'apalutamide.
CMAJ
; 196(7): E242, 2024 Feb 25.
Artigo
em Francês
| MEDLINE | ID: mdl-38408780
12.
Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract
; 25(6): 1293-1300, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945535
13.
Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.
Can J Urol
; 26(6): 10045-10053, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860422
14.
Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).
J Cancer Educ
; 34(1): 14-18, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779441
15.
Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors.
Br J Cancer
; 118(10): 1313-1321, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736007
16.
Hypothyroidism caused by apalutamide.
CMAJ
; 195(42): E1443, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903525
17.
Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.
Cancer
; 123(20): 4057-4065, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28708930
18.
The role of the built environment in a randomized controlled trial to increase physical activity among men with prostate cancer: the PROMOTE trial.
Support Care Cancer
; 25(10): 2993-2996, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28656468
19.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 122(3): 411-9, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26540173
20.
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC).
Invest New Drugs
; 34(6): 771-776, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565809